ALNYLAM PHARMACEUTICALS, INC. reports

Company location: Cambridge, MA
Fiscal year end: 31 December

ALNYLAM PHARMACEUTICALS, INC. has filed 1,677 SEC EDGAR filings since 09 Jul 2002

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 351-375 of 1,000 matching filings.

Per page

25

Current page

15

4

PRIMARY DOCUMENT

Filing date: 05 Aug 2022
Reporting date: 03 Aug 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 05 Aug 2022
Reporting date: 03 Aug 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 05 Aug 2022
Reporting date: 03 Aug 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-36407

10-Q

Filing date: 28 Jul 2022
Reporting date: 30 Jun 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36407

ALNYLAM PHARMACEUTICALS, INC. 8-K

Filing date: 28 Jul 2022
Reporting date: 28 Jul 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 07 Jul 2022
Reporting date: 05 Jul 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36407

8-K

Filing date: 14 Jun 2022
Reporting date: 13 Jun 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36407

8-K

Filing date: 23 May 2022
Reporting date: 18 May 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 20 May 2022
Reporting date: 18 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 20 May 2022
Reporting date: 18 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 20 May 2022
Reporting date: 18 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 20 May 2022
Reporting date: 18 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 20 May 2022
Reporting date: 18 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 20 May 2022
Reporting date: 18 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 20 May 2022
Reporting date: 18 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 20 May 2022
Reporting date: 18 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-36407

10-Q

Filing date: 28 Apr 2022
Reporting date: 31 Mar 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36407

ALNYLAM PHARMACEUTICALS, INC. 8-K

Filing date: 28 Apr 2022
Reporting date: 28 Apr 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

DEFA14A File 001-36407

DEFA14A

Filing date: 05 Apr 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14A File 001-36407

DEF 14A

Filing date: 05 Apr 2022
Reporting date: 18 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36407

8-K

Filing date: 05 Apr 2022
Reporting date: 31 Mar 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 05 Apr 2022
Reporting date: 01 Apr 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36407

8-K

Filing date: 04 Apr 2022
Reporting date: 04 Apr 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36407

8-K

Filing date: 17 Mar 2022
Reporting date: 17 Mar 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 25 Feb 2022
Reporting date: 23 Feb 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .